Supports transformative research and innovation to reduce treatment toxicity and adverse effects of brain cancer therapies, improving quality and length of life for people with brain cancer and their carers. Administered by NHMRC on behalf of the Australian Government Department of Health, Disability and Ageing, and Cancer Australia.
Eligibility Criteria:
-
Eligible Australian research organisations and investigators conducting brain cancer research.
-
Projects must develop novel approaches to reduce short- and/or long-term treatment toxicity and adverse effects.
-
Applications submitted in accordance with NHMRC/Sapphire and institutional requirements.
Funding Details:
-
Grants of financial assistance under the Medical Research Future Fund (MRFF).
-
Aims to reduce burden from treatment and improve health and wellbeing through evidence-based, implementable outcomes.
Deadline:
-
Applications Open: 03 September 2025.
-
Minimum Data Due: 21 January 2026.
-
Applications Close: 04 February 2026.
Where To Go For Further Information:
-
MRFF grant opportunities page.